IPO registrations (S-1, F-1) · Registrants
ABATTIS BIOCEUTICALS CORP
- SEC CIK
- 1515768 · filings on EDGAR ↗
- Former names
- ABATTIS BIOLOGIX Corp (2011–2012)
- Registration
- Form F-1, first filed 2015-04-28; 1 initial registration, 0 amendments
- Outcome
- Withdrawal requested 2016-12-09
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- A1
- Business address
- SUITE 1000 - 355 BURRARD STREET, Vancouver, A1 V6C 2G8
- EDGAR entity type
- other
Offering terms
- Shares offered
- 180,000,000
- Listing
- OTCQX under the symbol ATTBF
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form D issuer: ABATTIS BIOCEUTICALS CORP EXACT (CIK (EXACT))
Filings 2
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2015-04-28 | F-1 | F-1 (foreign registration) | ABATTIS BIOCEUTICALS CORP | 0001221508-15-000005 ↗ |
| 2016-12-09 | RW | RW (withdrawal request) | ABATTIS BIOCEUTICALS CORP | 0001176256-16-000712 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2015-04-28 | F-1 | registration statement | 180,000,000 | - | OTCQX ATTBF | 0 | primary document; shares headline | document ↗ |
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2014-04-14 | ABATTIS BIOCEUTICALS CORP | Other Health Care | $62,554 | $62,554 | 1 | 1 |
| 2014-04-03 | ABATTIS BIOCEUTICALS CORP | Other Health Care | $2,489,145 | $83,709 | 6 | 1 |
| 2012-03-21 | ABATTIS BIOLOGIX Corp | Biotechnology | $20,014 | $20,014 | 1 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | ABATTIS BIOCEUTICALS CORP | Form D private offerings | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, A1 first:
- ONCOGENEX TECHNOLOGIES INC A1
- Aspreva Pharmaceuticals CORP A1
- Lexaria Bioscience Corp. A1
- Zymeworks BC Inc. A1
- BetterLife Pharma Inc. A1
- BriaCell Therapeutics Corp. A1
- Old API Wind-down Ltd. A1
- AbCellera Biologics Inc. A1
- BODY & MIND INC. A1
- XORTX Therapeutics Inc. A1
In other datasets, the same topic (Health) in A1:
- Form D issuer: 1219014 B.C. Ltd. (Form D private offerings)
Interests: Pharmaceutical Preparations · Health